HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

immunotoxin 4D5MOCB-ETA

the immunotoxin 4D5MOCB-ETA was developed by genetically fusing a truncated form of Pseudomonas aeruginosa exotoxin A (ETA) (ETA(252-608)KDEL) to the highly stable humanized single-chain antibody fragment (scFv) 4D5MOCB; has potent and selective antitumor activity
Also Known As:
4D5MOCB-ETA
Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Di Paolo, Claudio: 1 article (07/2003)
2. Kubetzko, Susanne: 1 article (07/2003)
3. Lauffer, Ikar: 1 article (07/2003)
4. Plückthun, Andreas: 1 article (07/2003)
5. Stahel, Rolf A: 1 article (07/2003)
6. Tschudi, Dominique: 1 article (07/2003)
7. Waibel, Robert: 1 article (07/2003)
8. Willuda, Jörg: 1 article (07/2003)
9. Zangemeister-Wittke, Uwe: 1 article (07/2003)

Related Diseases

1. Squamous Cell Carcinoma of Head and Neck
2. Neoplasms (Cancer)
3. Squamous Cell Carcinoma (Epidermoid Carcinoma)
4. Carcinoma (Carcinomatosis)

Related Drugs and Biologics

1. Proteins (Proteins, Gene)
2. Epithelial Cell Adhesion Molecule